F2756
荧光素二(β-D-吡喃半乳糖苷)
别名:
FDG
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C32H32O15
化学文摘社编号:
分子量:
656.59
MDL编号:
UNSPSC代码:
12352201
PubChem化学物质编号:
NACRES:
NC.07
方案
≥98% (HPLC)
质量水平
表单
powder
溶解性
methanol: 20 mg/mL, clear, yellow
储存温度
−20°C
SMILES字符串
OC[C@H]1O[C@@H](Oc2ccc3c(Oc4cc(O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)ccc4C36OC(=O)c7ccccc67)c2)[C@H](O)[C@@H](O)[C@H]1O
InChI
1S/C32H32O15/c33-11-21-23(35)25(37)27(39)30(45-21)42-13-5-7-17-19(9-13)44-20-10-14(43-31-28(40)26(38)24(36)22(12-34)46-31)6-8-18(20)32(17)16-4-2-1-3-15(16)29(41)47-32/h1-10,21-28,30-31,33-40H,11-12H2/t21-,22-,23+,24+,25+,26+,27-,28-,30-,31-/m1/s1
InChI key
ZTOBILYWTYHOJB-WBCGDKOGSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
β-半乳糖苷酶的荧光底物
应用
荧光素二(β-D-吡喃半乳糖苷)已用作β-半乳糖苷酶试验中的底物。
荧光素二(β-D-吡喃半乳糖苷)（FDG）已可用于通过FACS（荧光激活细胞分选）检测基因表达。
生化/生理作用
荧光素二(β-D-吡喃半乳糖苷)(FDG被β-半乳糖苷酶水解成荧光素后发出荧光。它能产生与酶活性成比例的荧光。当使用β-半乳糖苷酶（Lac Z）作为报告基因时，该分子主要用于检测转染细胞中的基因表达。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
Jose M Anton-Rodriguez et al.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 40(6), 826-835 (2019-04-30)
To investigate whether [F]fluorothymidine (FLT) and/or [F]fluorodeoxyglucose (FDG) positron emission tomography (PET) can differentiate growth in neurofibromatosis 2 (NF2) related vestibular schwannomas (VS) and to evaluate the importance of PET scanner spatial resolution on measured tumor uptake. Six NF2 patients
Michael Peter Jones et al.
Radiation oncology (London, England), 14(1), 140-140 (2019-08-08)
To investigate the prognostic significance of positron emission tomography (PET) parameters from F-18 fluorodeoxyglucose (FDG) PET scans performed pre- and post- chemo-radiotherapy (CRT) for squamous cell carcinoma of the anal canal (AC). From January 2013 to January 2017, 19 patients
Dominik Berzaczy et al.
Cancers, 12(1) (2019-12-22)
The response evaluation criteria in lymphoma (RECIL) classification for lymphoma treatment response assessment was introduced in 2017, but it has not yet been compared to the established Lugano classification. Also, the value of the provisional "minor response" (MiR) category of
N K Grzimek et al.
Journal of virology, 73(6), 5043-5055 (1999-05-11)
Transcription of the major immediate-early (MIE) genes of cytomegaloviruses (CMV) is driven by a strong promoter-enhancer (MIEPE) complex. Transactivator proteins encoded by these MIE genes are essential for productive infection. Accordingly, the MIEPE is a crucial control point, and its
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
David Lh Chan et al.
Theranostics, 7(5), 1149-1158 (2017-04-25)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持